Our data were in line with Mikłosz et al. (2022), who stated that MSC-Exo-based therapy was sufficient to reduce body fat mass in diet-induced obesity animals and suppress the increase in body weight, which could be related to the promotion of insulin production, improvement of insulin resistance, and regulation of hepatic metabolism. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.